Clinical Application of exhaled Nitric Oxide measurements in PrimarY care
Recruiting
- Conditions
- AsthmaRespiratory - Asthma
- Registration Number
- ACTRN12605000354684
- Lead Sponsor
- niversity of Otago
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Diagnostic arm: Inclusion - patients over 12yrs old with wheeze, cough or dyspnoea for >6weeks duration. Treatment arm: Inclusion - asthmatic patients >12yrs old.
Exclusion Criteria
Exclusion for both arms current or recent ex-smokers (<6months).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie exhaled nitric oxide's role in asthma diagnosis and monitoring?
How does exhaled nitric oxide measurement compare to spirometry in primary care asthma management?
Which biomarkers correlate with exhaled nitric oxide levels in predicting asthma treatment response?
What adverse events are associated with inhaled corticosteroids in asthma patients using exhaled nitric oxide monitoring?
Are there alternative biomarkers or technologies to exhaled nitric oxide for asthma management in primary care?